Advertisement
UK markets close in 3 hours 37 minutes
  • FTSE 100

    7,861.14
    -104.39 (-1.31%)
     
  • FTSE 250

    19,435.68
    -263.21 (-1.34%)
     
  • AIM

    741.59
    -8.69 (-1.16%)
     
  • GBP/EUR

    1.1701
    -0.0010 (-0.08%)
     
  • GBP/USD

    1.2459
    +0.0013 (+0.10%)
     
  • Bitcoin GBP

    50,350.79
    -2,730.33 (-5.14%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • S&P 500

    5,061.82
    -61.59 (-1.20%)
     
  • DOW

    37,735.11
    -248.13 (-0.65%)
     
  • CRUDE OIL

    85.05
    -0.36 (-0.42%)
     
  • GOLD FUTURES

    2,388.50
    +5.50 (+0.23%)
     
  • NIKKEI 225

    38,471.20
    -761.60 (-1.94%)
     
  • HANG SENG

    16,248.97
    -351.49 (-2.12%)
     
  • DAX

    17,849.05
    -177.53 (-0.98%)
     
  • CAC 40

    7,966.71
    -78.40 (-0.97%)
     

Upbeat broker recommendations for AVEVA

The AVEVA (LON:AVV) share price has risen by 18.1% over the past month and it’s currently trading at 2,273p. For investors considering whether to buy, hold or sell the stock, the question now is whether this price run will continue.

According to the company’s analysts, there are certainly reasons to think it will continue to perform well in the year ahead. In terms of trading recommendations, AVEVA currently has:

  • 4 Buy recommendations

  • 7 Hold recommendations

  • 1 Sell recommendations

This suggests that analysts are generally positive about the outlook.

GET MORE DATA-DRIVEN INSIGHTS INTO LON:AVV »

Looking behind the broker forecasts

At its current price of 2,273p, shares in AVEVA are trading at a discount of -46.4% to its 52 week high price. The 1-year performance of the shares has been -34.1%.

While analyst forecasts can be a useful guide to what City 'experts' think about a stock's near term future, they can be unreliable. To get a better idea about the strengths and weaknesses of AVEVA it's worth doing some investigation yourself. Indeed, we've identified some areas of concern with AVEVA that you can find out about here.